Recommended public cash offer of Amgen Inc. to the shareholders of Nuevolution AB (publ)

Important Information

The information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.